Image Description (Description)
Oxaliplatin Injection, Solution
Product Images NDC 42677-337
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxaliplatin (NDC 42677-337). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Shandong New Time Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image Description (Figure1)
The provided text appears to be a table showing the DFS (Disease-Free Survival) probability statistics for different time periods (in months). It includes information on the number of events, arm numbers, ratios with confidence intervals, and test results. There are percentages and patient counts also mentioned. This data seems to be related to a research study or clinical trial evaluating DFS in patients.*
Image Description (Figure2)
The text provides information related to DFS (disease-free survival) probability along with time intervals in months (12, 18, 24, etc.). It also mentions two treatment arms - FOLFOX4 and LV5FU2 - for DUKES C and DUKES ¢. Additionally, there is a Hazard Ratio with a confidence interval of 96% and Lograni Test result with p-value.*
Image Description (Figure3)
This data table compares median survival times in months for patients receiving Oxaliplatin Injection USP with either 5-FUILV or irinotecan. The percentage of patients surviving over time is also shown. The statistical significance of the results is indicated by the p-value. The table utilizes the log-rank test to compare the two treatment groups.*
Image Description (Carton 100mg)
This text contains information about Oxaliplatin injection, USP, which is a cytotoxic agent used for intravenous infusion after dilution. Each single-dose vial contains 100 mg of Oxaliplatin in a sterile aqueous solution. The prescription information includes dosage and administration details, precautions, and storage recommendations. It is advised to wear gloves when handling the containers, store at 25°C, and protect from light. Unused portions should be discarded following guidelines provided. The manufacturer of the product mentioned in the text is Shandong New Time Pharmaceutical Co. Ltd.*
Image Description (Carton 50mg)
This is a description of the medication Oxaliplatin in the form of an injection. It is a sterile, preservative-free solution for intravenous infusion after dilution. Each single-dose vial contains 50 mg of Oxaliplatin. The dosage and administration details are provided on the label. It is important to follow proper prescribing information for correct dosage, usage directions, and precautions. Protective measures like wearing gloves during handling are recommended. The medication should be stored at 25°C (77°F), with limited excursions permitted. It must not be frozen and should be protected from light. Unused portions should be discarded properly. Additionally, there are specific instructions regarding storage and precautions related to diluted solutions. It is emphasized not to mix or add Oxaliplatin to sodium chloride/chloride-containing solutions. The medication is manufactured by Shandong New Time Pharmaceutical Co., Ltd.*
Image Description (Container 100mg)
This is a description for Oxaliplatin Injection, USP with a concentration of 100 mg/20 mL (5 mg/mL). It is a cytotoxic agent for intravenous infusion after dilution. The warning advises not to mix or add to sodium chloride/chloride-containing solutions. Each vial contains 100 mg of oxaliplatin and Water for Injection, USP (20 mL). The storage temperature is recommended at 25°C (77°F) with excursions permitted to 15-30°C (59°-86°F) and should not be frozen. It must be protected from light and any unused portion should be discarded per package instructions. The manufacturer is Shandong New Time Pharmaceutical Co., Ltd. in Feixian, Linyi, Shandong, China.*
Image Description (Container50mg)
This is a description of Oxaliplatin Injection, USP. Each vial contains 50 mg of oxaliplatin in a 10 mL solution. It is a cytotoxic agent used for intravenous infusion after dilution. The medication should be stored at 25°C (77°F) with excursions permitted, and after dilution, it should be stored at 15-30°C (59°-86°F) without freezing. It must be protected from light and discarded if unused. It warns not to mix or add to sodium chloride-containing solutions. The product is manufactured by Shandong New Time Pharmaceutical Co., Ltd in China.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
